Over 1500 Total Lots Up For Auction at Four Locations - CA 01/24, TX 01/30, UT 01/31, NJ Cleansweep 02/06

GenesisCare selects Mirada Medical radiotherapy imaging software

Press releases may be edited for formatting or style | May 05, 2017 Rad Oncology Radiation Therapy
OXFORD, 3 May 2017 – Mirada Medical Ltd, a leading global provider of medical imaging software announced today that GenesisCare UK and GenesisCare Spain, part of GenesisCare International, have selected Mirada’s radiotherapy software for deformable image registration, contouring and adaptive therapy across their network of 32 cancer centres.

GenesisCare's focus is on making leading-edge technology available to their patients, alongside a consistent attention to patient-friendly, individualised care for efficient cancer treatments.

As part of the contract, Oxford-based Mirada Medical are delivering their radiotherapy imaging software RTxTM for deformable image registration, contouring and adaptive therapy, as well as Workflow BoxTM, for zero-click auto-contouring and adaptive re-contouring of organs-at-risk, to the whole collaborative network.

"Mirada Medical is a perfect partner to deliver on our mission to provide the best possible patient care in radiotherapy across our European cancer centre network.” says Carlos Rodrigues, Clinical Development Manager - International at GenesisCare. ”The quality of their deformable image registration technology, combined with efficient automation and user friendly user interface enables us to provide patients with the most precise treatment available and our team with a very efficient platform.”

"We are delighted to partner with GenesisCare in the UK and Spain, providing them with our state-of-the-art software technology to support their mission to provide the highest levels of patient-focused cancer care efficiently across their networks. Our radiotherapy software platform will enable that through robust image registration, as well as efficient workflows for contouring and adaptive therapy”, said Matthieu Leclerc-Chalvet, Managing Director of Mirada Medical.

You Must Be Logged In To Post A Comment